ME/CFS Symptoms & Biology
Post-exertional malaise, brain fog, unrefreshing sleep and pain — what each ME/CFS symptom actually is, which subset it points to, and the biology driving it.
Clinical Picture
Symptoms & Subsets
ME/CFS is not a single symptom - it is a constellation of symptoms that vary in type, severity, and combination across individuals. Researchers increasingly recognize distinct patient subsets.
- Post-exertional malaise (PEM) is the cardinal symptom: a disproportionate worsening of symptoms after exertion. Onset varies - 72% of patients experience immediate onset from some triggers (especially physical), while 91% also experience delayed onset hours to days later. This is not ordinary tiredness.
- Brain fog, unrefreshing sleep, and orthostatic intolerance (dizziness on standing) are core features alongside profound fatigue.
- Symptoms fluctuate daily and worsen cyclically - especially in women around the menstrual phase.
- Severity ranges from mildly limited to completely bedbound - 25% are housebound or bedbound.
Post-Exertional Malaise (PEM)
The cardinal feature. A prolonged, often delayed worsening of all symptoms following physical, cognitive, emotional, sensory, or social exertion - even activity that was previously well-tolerated. Also called a "crash" or "flare." Onset is highly variable and most patients experience both patterns. Physical triggers (especially standing, orthostatic stress) often cause immediate or within-hours onset. Cognitive, emotional, and sustained moderate exertion more often produce delayed onset 12-48 hours later - occasionally up to 7 days. A 2019 patient survey of 1,534 ME/CFS patients found 72% had experienced immediate-onset PEM and 91% had experienced delayed-onset PEM - most patients experience both depending on the trigger. Duration ranges from days to months. This is a biological event, not psychological.
"Imagine spending Saturday at a family dinner - two hours, easy conversation, one plate of food. Monday morning you wake up unable to lift your arms. Your legs feel submerged in concrete. Every joint aches like you have a fever. Your brain cannot form a sentence. This is PEM. The dinner caused it. You had no warning while you were there."
Full crash trigger guide → What a crash looks and feels like →
Unrefreshing Sleep
Patients do not feel better or less tired after a full night of sleep - regardless of whether they slept 6 hours or 14. This may persist even without identifiable objective sleep abnormalities on polysomnography, though many patients show disrupted sleep architecture including reduced slow-wave (restorative) sleep and altered circadian rhythms.
"It's like sleeping inside a car engine. The noise never stops. You wake up exactly as exhausted as when you lay down - sometimes more so, as if the effort of sleeping itself consumed the little energy you had. You have slept 10 hours. You feel like you have not slept at all. Every single morning."
The REM dysregulation documented in ME/CFS also creates the neurological conditions for sleep paralysis - episodes where the brain wakes from REM sleep before the body's paralysis resolves. Patients find themselves conscious but unable to move, often with vivid and terrifying hallucinations: a sense of a dark presence in the room, chest pressure, difficulty breathing, or the sensation of being held down. Culturally described across history as "the old hag," demonic possession, or night terrors - now understood as a REM-sleep transition disorder made more likely by ME/CFS sleep architecture disruption.[Sleep paralysis: PMC11344621, PMC12349844; REM dysregulation in ME/CFS: PMC3501671]
Profound Fatigue
Not ordinary tiredness. This is a severe, debilitating fatigue that has substantially reduced the ability to engage in pre-illness activity levels - occupational, educational, social, or personal. It must be present for 6 months or more, cannot be explained by excessive exertion, and is not substantially alleviated by rest.
"Imagine wearing a full suit of armor soaked in water, weighing 100 pounds. That is your body. Every movement - lifting a glass, turning your head, walking to the bathroom - requires that weight to be carried. Now imagine trying to do this after three days without sleep, with a fever, and with the flu. That is ME/CFS fatigue. Not tiredness. Not needing a nap. An anchor attached to every limb."
A patient quoted in the IOM 2015 report described it as: "permanently having the flu, a hangover, and jet lag while being continually electrocuted."[3]
Cognitive Impairment ("Brain Fog")
Problems with thinking, memory, executive function, attention, and information processing. Sometimes called "brain fog." Can be exacerbated by exertion, upright posture, stress, or time pressure. May be severe enough to prevent work, reading, or following conversation.
"Mid-sentence, the word you were about to say disappears completely. Not on the tip of your tongue - gone. You are trying to read a paragraph you have read three times. The words make individual sense but your brain cannot assemble them into meaning. You cannot remember if you took your medication five minutes ago. You are not stupid. Your brain is running on a dying battery, and the first things to go are the complex processes - language, memory, sequencing, planning."
Orthostatic Intolerance (OI)
Worsening of symptoms upon standing or sitting upright. Includes lightheadedness, racing heart, blurred vision, presyncope, and in many patients a distressing sensation of air hunger or breathlessness. Measured forms include POTS (Postural Orthostatic Tachycardia Syndrome), NMH (Neurally Mediated Hypotension), and OI without tachycardia.
"Standing up feels like being pulled backward into the floor. Within seconds of getting upright, the room begins to blur, your heart hammers, and a grey tunnel closes around your vision. Your brain is not getting enough blood. Lying down brings partial relief. For many patients, standing in line at a pharmacy - just standing still - is more physiologically demanding than walking a block."
Dysautonomia: The Autonomic Nervous System in ME/CFS
Dysautonomia is a broad term for any condition involving dysfunction of the autonomic nervous system (ANS) - the part of the nervous system that controls all involuntary body functions. This includes heart rate, blood pressure, breathing rate, digestion, temperature regulation, sweating, bladder function, and pupil response. The ANS operates entirely below conscious control, running automatically in the background to keep the body in balance (homeostasis).
The ANS has two main branches: the sympathetic system (the "fight-or-flight" response - speeds heart rate, raises blood pressure, diverts blood to muscles) and the parasympathetic system (the "rest-and-digest" response - slows heart rate, promotes digestion and recovery). In health, these two branches work in dynamic balance. In ME/CFS, this balance is disrupted.
How dysautonomia develops in ME/CFS: Research shows ME/CFS involves sympathetic overactivation and parasympathetic underactivation - measured as reduced heart rate variability (HRV) and abnormal cardiovascular responses to postural changes. The likely mechanisms include small fiber neuropathy (damage to the nerve fibers that carry autonomic signals), GPCR autoantibodies disrupting receptor signaling in blood vessels and the heart, neuroinflammation affecting autonomic control centers in the brainstem, and impaired microcirculation reducing oxygen delivery to autonomic nerve tissue.[12,16,17]
Why it matters clinically: Dysautonomia in ME/CFS explains many of the most disabling symptoms - the crashes after standing, the brain fog that worsens upright, the inability to tolerate heat, the digestive dysfunction, and the profound fatigue that follows even mild activity. It is one of the most undertested aspects of ME/CFS; many patients spend years without a tilt table test or even a basic 10-minute standing test, and their dysautonomia goes undiagnosed and untreated. Named dysautonomia syndromes found in ME/CFS include POTS, Neurally Mediated Hypotension (NMH), and Orthostatic Hypotension - described in detail below.[16]
Specific autonomic manifestations found in ME/CFS patients:
POTS
Postural Orthostatic Tachycardia Syndrome - heart rate rises ≥30 bpm within 10 minutes of standing, as blood pools in the legs and the heart races to compensate. Causes dizziness, palpitations, fatigue, and brain fog that worsens markedly when upright.
Air hunger and shallow breathing
Approximately one third of POTS patients experience dyspnea - an uncomfortable sensation of breathlessness or air hunger - that has nothing to do with the lungs.[40] The mechanism is vascular, not pulmonary: when upright, thoracic blood volume drops sharply, reducing cardiac output. The carotid body - a tiny chemoreceptor cluster near the carotid artery - detects this hypoperfusion and triggers a hyperventilation reflex as a compensatory response.[40] The result is rapid, shallow breathing that paradoxically worsens the sensation of breathlessness - breathing faster does not solve a blood volume problem.
Dysfunctional breathing patterns are common in POTS: patients default to upper chest breathing rather than diaphragmatic breathing, and may unconsciously hyperventilate, driving CO₂ levels down and worsening dizziness, tingling, and cognitive symptoms.[41] This is frequently misdiagnosed as anxiety or a pulmonary condition.
What actually helps: breathing retraining
A 2024 study in the European Journal of Neurology found that slow, paced diaphragmatic breathing at 6 breaths per minute reduced standing heart rate by 7.35 bpm and significantly lowered symptom scores in POTS patients during orthostatic challenge.[41] Breathing retraining with a physiotherapist familiar with dysautonomia is the evidence-based first step - not anxiolytics or pulmonary workup.
What actually helps: treating the underlying blood volume problem
Because the breathlessness is vascular in origin rather than pulmonary, treatments that address thoracic hypovolemia may also reduce air hunger. The same interventions used to treat POTS broadly are the relevant ones here:[40]
- High fluid and salt intake (2-3L fluid daily, 10-12g sodium) - first-line, expands plasma volume directly
- Compression garments - reduce venous pooling in legs, increasing thoracic blood return
- Fludrocortisone - mineralocorticoid that increases sodium and water retention, expanding intravascular volume[42]
- Midodrine - alpha-1 agonist that increases vascular tone and reduces blood pooling[42]
- IV saline - for acute decompensation, rapidly expands blood volume and relieves symptoms for hours to days[42]
Note: dyspnea is listed as a recognised POTS symptom in clinical literature and volume expansion targets its root cause mechanistically. Breathlessness has not been isolated as a primary endpoint in POTS treatment trials, but clinical improvement in overall POTS symptom burden - which includes dyspnea - is well documented.
"Standing in a shower feels like standing on the deck of a boat in a storm. The heart is racing at 130 beats per minute. And somehow I cannot catch my breath even though my lungs are fine. Every inhale feels incomplete. It is like breathing through a damp cloth while someone sits on your chest - and the harder you breathe, the worse it gets."
Neurally Mediated Hypotension
Blood pressure drops suddenly when upright for extended periods, causing presyncope or syncope. Identified on tilt-table testing.
Reduced Cerebral Blood Flow
Studies using SPECT and transcranial Doppler imaging have documented reduced blood flow to the brain in ME/CFS, worsening with standing and cognitive load.
"The brain fog is not metaphorical - it is physiological. Less blood reaching the brain means less oxygen and glucose for neurons to function. The cognitive collapse that happens when patients stand up or exert themselves mentally is the brain literally running on reduced fuel."
Thermoregulatory Dysfunction
Difficulty regulating body temperature - feeling too hot or too cold regardless of ambient temperature. Low-grade fevers are common. The internal thermostat is broken.
"Simultaneously too hot and too cold. Sweating through sheets in a 65-degree room. Then, minutes later, shaking with chills. The body has lost the ability to self-correct, so temperature swings freely between extremes without reaching equilibrium."
Abnormal Sweating
Night sweats or excessive sweating disproportionate to temperature or activity. Alternatively, reduced sweating response (hypohidrosis) in some patients.
Autonomic GI Dysfunction
Nausea, gastroparesis (delayed stomach emptying where food sits in the stomach for hours rather than moving on normally), irritable bowel-like symptoms, and early satiety - driven by autonomic nervous system dysfunction rather than primary GI disease.
"Eating a small meal and feeling uncomfortably full for six hours. The stomach's motility - the muscular waves that move food along - is controlled by the autonomic nervous system, which in ME/CFS is dysregulated. Food sits, ferments, causes bloating, nausea, and pain - not because there is a GI disease, but because the signaling system that runs digestion has broken down."
Neurological symptoms are among the most disabling aspects of ME/CFS. Neuroimaging studies have documented objective brain changes.
Memory Impairment
Short-term and working memory failures. Difficulty forming new memories or retrieving stored ones. Worsens significantly with exertion.
Slowed Processing Speed
Reactions take longer; difficulty multitasking; slower reading comprehension and verbal processing. Documented on objective neuropsychological tests.
Sensory Hypersensitivity
Heightened sensitivity to light (photophobia), sound (phonophobia), touch, smell, and chemical exposures. Fluorescent lighting and noise are common crash triggers.
"A normal conversation in a restaurant - background music, cutlery sounds, multiple voices - arrives like a physical assault. It is not unpleasant noise. It is pain. The brain cannot filter it. By the end of the meal, which appeared normal from the outside, the patient is in neurological overload and will be crashing by morning."
Neuroinflammation
PET scan studies (Nakatomi et al., 2014; replicated in NIH 2024 intramural study) found significant neuroinflammation in multiple brain regions, particularly the thalamus, midbrain, and cingulate cortex.
Muscle Weakness & Fatigability
Muscles tire unusually quickly with minimal effort. Distinct from deconditioning - muscle biopsies show mitochondrial abnormalities and disrupted fiber architecture.
Headaches
New or changed pattern of headaches - often tension-type, migrainous, or pressure-like. May be related to intracranial pressure, inflammation, or vascular dysfunction.
Immune system dysregulation is a hallmark of ME/CFS and is a major focus of current research and therapeutic targeting.
Persistent Flu-like State
Ongoing sore throat (often viral pharyngitis-like), tender lymph nodes, low-grade fever or temperature instability, and general malaise resembling an unresolved infection.
"The body never got the message that the infection ended. The aching, the swollen glands, the feverish feeling - these persist for months or years. Not because a virus is still active, but because the immune system is stuck in an alarm state it cannot turn off."
Reduced NK Cell Function
Natural Killer (NK) cell cytotoxic function (not cell count) is significantly reduced and correlates with illness severity. This impairs the immune system's ability to control viral reactivation.
Chronic Cytokine Elevation
Elevated pro-inflammatory cytokines (IL-6, IL-8, TNF-α, TGF-β) found in blood and cerebrospinal fluid. These suppress mitochondrial function and disrupt energy metabolism.
Autoantibodies
A subset of patients have detectable autoantibodies against G-protein coupled receptors (β₂ adrenergic receptors, M3/M4 muscarinic receptors), thyroid peroxidase (TPO), and nuclear antigens. These correlate with autonomic symptoms and fatigue severity.
Mast Cell Activation
A significant subset of ME/CFS patients have comorbid Mast Cell Activation Syndrome (MCAS), producing widespread inflammation, sensitivities, and multi-system symptoms.
Herpesvirus Reactivation
EBV (Epstein-Barr), HHV-6, CMV reactivation is found in many patients - possibly due to impaired NK cell control. This fuels ongoing immune activation and symptoms.
Myalgia
Widespread muscle pain, often described as aching or burning. Distinct from fibromyalgia but frequently co-occurring. May fluctuate and worsen after activity.
"The aching is the closest thing to flu body pain you can imagine - but it does not go away after a week. It lives in the muscles like they have been wrung out like a wet cloth. On bad days, even the weight of a bedsheet pressing on skin feels like bruising."
Arthralgia
Joint pain without inflammation or swelling, often migratory (moving between joints). Frequently accompanies myalgia in ME/CFS.
Neuropathic & Abdominal Pain
Burning, tingling, electric shock sensations; abdominal cramping and pain (often mistaken for IBS). May involve small-fiber neuropathy, documented on skin biopsy in some patients.
"Random jolts of electric-shock pain. A burning in the feet as if standing on hot sand. Shooting pain that travels up a limb without warning. The small nerve fibers that transmit pain signals are damaged and misfiring - sending pain signals in the absence of any injury."
Allodynia
Pain from normally non-painful stimuli - light touch, clothing, or gentle pressure causing disproportionate discomfort. Indicates central sensitization of the pain signaling system.
"A hug from a loved one can feel like being squeezed by a vice. A cotton T-shirt feels like sandpaper on sunburned skin. The nerves have lost their sense of proportion - everything is amplified, as if the volume knob on pain has been turned to its maximum."
Chest Pain
Non-cardiac chest pain, often sharp or pressure-like. Can be related to costochondritis, dysautonomia, or inflammation.
Fibromyalgia Overlap
Up to 70% of ME/CFS patients also meet fibromyalgia diagnostic criteria. Both involve central sensitization, but ME/CFS is distinguished primarily by PEM.
Disrupted Sleep Structure + Sleep Paralysis
Reduced slow-wave (restorative) sleep. Alpha-wave intrusion into delta sleep - the brain keeps inserting wakeful rhythms into deep sleep, preventing the restoration that deep sleep normally provides. Many patients wake frequently, sometimes every hour.
"You sleep 12 hours and wake up as if you have not slept at all. Not groggy - genuinely unrestored, as if sleep itself did not happen at a biological level."
Sleep paralysis: ME/CFS disrupts REM sleep architecture, creating the neurological conditions under which sleep paralysis occurs more readily: the brain wakes from REM before the body's muscle atonia resolves, leaving the person conscious but unable to move or speak - often for seconds to minutes. More than 75% of sleep paralysis episodes involve hallucinations: a dark figure in the room ("the intruder"), crushing chest pressure as if something is sitting on the chest ("the incubus"), difficulty breathing, or an overwhelming sense of an evil presence. Historically described as demonic possession or supernatural attack across cultures worldwide; neurologically, it is REM-wake overlap creating vivid waking nightmare states. Distressing but not dangerous - it resolves on its own.
Delayed Sleep Phase
Many patients develop DSPS (Delayed Sleep Phase Syndrome) - unable to fall asleep before 2-4am regardless of how tired they are, then unable to wake at normal times. The internal clock has shifted several hours forward. Related to disrupted melatonin signaling and HPA dysregulation.
"The body's clock has been permanently set to a different timezone. Midnight feels like late afternoon. 10am feels like the middle of the night. Forcing yourself to conform to a normal schedule - for appointments, for family, for work - costs enormous energy and crashes the system."
Hypersomnia or Insomnia
Some patients sleep 10-14 hours and still feel completely unrefreshed. Others cannot sleep despite exhaustion - the nervous system too activated to allow sleep onset. Both presentations occur in the same patient and can alternate, sometimes in the same week.
"The cruelest paradox: too exhausted to stay awake, too wired to fall asleep. Lying in bed for hours, the body screaming for rest, the nervous system refusing to power down. Then sleeping for 12 hours and waking feeling worse."
Sleep Apnea Overlap
Comorbid sleep apnea (obstructive or central) is common and should be assessed and treated. Treatment does not resolve ME/CFS but improves baseline function.
The 2025 PNAS study (Komaroff et al.) analyzing over 3,900 patients identified distinct symptom-based subgroups with different treatment responses - supporting the growing understanding that ME/CFS is not a single homogeneous condition.[36]
Autonomic-Dominant
Primarily POTS, NMH, and dysautonomia. Often responds best to salt/fluid loading, compression garments, beta-blockers, and fludrocortisone. May have a strong cardiovascular component. Frequently co-occurs with MCAS and hEDS in what is sometimes called the "trifecta."
Inflammatory / Immunological
Prominent flu-like symptoms, elevated cytokines, detectable autoantibodies. May respond to low-dose naltrexone (LDN), antivirals, or immunomodulatory approaches. More likely to test positive for GPCR autoantibodies. Often overlaps with post-infectious and neurological subsets.
Neurological / Cognitive
Brain fog and cognitive symptoms dominate. Neuroinflammation more prominent on imaging. May benefit from approaches targeting neuroinflammation or cerebral blood flow (e.g., low-dose aripiprazole, mestinon). Severe cases in this subset are often also bedbound.
Post-Infectious
Clear infection trigger (EBV, SARS-CoV-2, enterovirus, etc.). May have ongoing viral reactivation. Antiviral approaches (valacyclovir, Paxlovid trials) most relevant. Often overlaps with the inflammatory subset due to shared immune activation pathways.
MCAS-Predominant
Mast cell activation is a primary driver. Multi-system reactions to foods, chemicals, and environmental triggers. Responds to antihistamines (H1/H2 blockers), mast cell stabilizers (cromolyn), and low-histamine diet. Very commonly co-occurs with autonomic dysfunction and hEDS.
The Most Severely Affected: Multiple Failing Systems
About 25% of ME/CFS patients are severely affected - unable to leave bed or home, and profoundly sensitive to light, sound, touch, and exertion.[2,3] This is not simply a "more intense" version of a single subset. Clinical observation and the PNAS 2025 patient data consistently show that the most severely ill patients are carrying the highest burden of overlapping subset pathology simultaneously:
- Severe autonomic dysfunction - may be unable to sit upright at all; cerebral blood flow critically reduced; even minimal positional changes cause crashes
- Severe immune dysregulation - ongoing herpesvirus reactivation, high autoantibody titers, persistently elevated cytokines that suppress energy metabolism
- Severe neuroinflammation - hypersensitivity to all sensory input; extreme cognitive impairment; some patients cannot tolerate conversation or screens
- Severe mitochondrial failure - ATP production so impaired that basic daily activities consume the full energy budget; PEM crashes from brushing teeth or speaking
- Often comorbid MCAS - multi-system reactions compound the sensory and inflammatory burden
This multi-system convergence explains why severely ill patients are often underrepresented in clinical trials (they cannot travel or tolerate procedures) and why single-mechanism treatments tend to have limited impact in this group. Management must account for all active pathways, proceed with extreme caution, and prioritize energy preservation above all else.
Baseline Severity Levels
These are not crash categories - they describe a patient's baseline functional level when not in a crash. Crashes cause temporary worsening below baseline for any severity level. Severity is not fixed: it can change over time, and most commonly worsens with repeated crashes.
Able to carry out daily activities with significant modification and rest. May still work, study, or socialise - but at considerable personal cost. Often invisible to others, which creates its own pressure.
A particular burden of mild severity: Patients get moments of normality that make it hard to understand why they cannot maintain consistency. The pressure to keep up with others is enormous - and repeatedly pushing through those "better" moments is how many patients make themselves significantly worse. The illness may not yet be fully recognised by the patient themselves. Light and sound sensitivity may be minimal or absent. Orthostatic symptoms may be subtle.
Roughly 25% of ME/CFS patients.
Reduced mobility and restricted in daily activities. May have stopped working. Rest periods are necessary, often including daytime rests. Sleep is disturbed and unrefreshing. PEM is a regular feature of life.
Roughly 50% of ME/CFS patients.
Unable to leave home or largely housebound. All activities of daily living are affected. Significant cognitive impairment. Sensory sensitivities (light, sound, touch) are common and can be severe. Mobility often significantly impaired - walking may be impossible or very limited. A wheelchair may be necessary indoors.
Note on mobility and standing: Difficulty walking or standing is not exclusively a POTS/dysautonomia symptom. Many severe ME/CFS patients experience profound leg weakness and brain-body disconnection that makes standing and walking impossible regardless of heart rate or blood pressure. The neurological component of ME/CFS affects motor function directly.
Roughly 20% of ME/CFS patients.
Largely or completely bedbound. Dependent on care for basic activities. Minimal stimulation tolerated - some patients cannot tolerate any light, sound, or conversation. Tube feeding may be required. This is a catastrophic level of disability by any medical standard.
Roughly 25% of ME/CFS patients are housebound or bedbound combined (severe + very severe).
The severity levels above describe your baseline - what life looks like on a typical day between crashes, not during one. A crash (PEM episode) is a temporary worsening below that baseline for any severity level. This means:
- A mild ME/CFS patient can have crashes that temporarily look and feel severe
- A severe ME/CFS patient can have crashes that push them temporarily into very severe territory
- Crash descriptions elsewhere in this guide describe what happens during a PEM episode - they are not a description of any particular severity level's baseline
For this reason, mild patients reading the crash descriptions should not use those to judge their own baseline or daily experience - crashes are temporary departures, not your permanent reality. Equally, the detailed symptom lists in this guide apply most comprehensively to moderate and severe presentations at baseline. If you are mild, many of those symptoms may only appear during crashes, or not at all.
What a Crash (PEM) Actually Looks and Feels Like
A crash is not simply being tired. It is a measurable, physiological deterioration across multiple body systems. Understanding what it looks like from the inside and the outside is essential for both patients and everyone around them. For family and caregivers: how to respond during a crash →
Onset phase (hours 0-12 after trigger):
- Hitting the wall: A distinct, recognizable moment of "the plug being pulled" - not gradual tiredness but a sudden, specific shift. Patients learn to recognize it; it signals an incoming crash within hours.
- Lead body: Muscle weakness disproportionate to any exertion - legs feel submerged in concrete, arms too heavy to lift, fingers too weak to type. Not soreness. Structural failure of strength.
- The flu without the virus: A specific, flu-like malaise qualitatively different from ordinary tiredness - the aching-all-over feeling of a fever, skin so hypersensitive that clothing feels painful, a feverish sensation without measurable fever. Patients who have had both describe PEM malaise as indistinguishable from the worst day of a severe flu.
- Brain fog descending: Words disappear mid-sentence. Concentration collapses as if a switch was flipped. Simple decisions become genuinely impossible - choosing between two options can take minutes of effortful thought.
- Sensory assault: Light and sound shift from uncomfortable to physically painful. A normal conversation feels like shouting. Normal daylight requires sunglasses indoors.
- Heart and circulation: Heart rate spikes inappropriately, irregularities develop; dizziness or pre-syncope on standing. The cardiovascular system is failing to maintain adequate blood pressure and flow.
- Air hunger / dyspnea: For many patients this is a continuous baseline symptom - a persistent, low-level sense that each breath is slightly insufficient, like breathing through a damp cloth. It is present at rest and does not require exertion to trigger. This is autonomic dysregulation of respiratory drive, not a lung problem: the lungs themselves are healthy. During a crash, this baseline breathlessness can escalate sharply. Autonomic destabilisation during PEM intensifies the hyperventilation reflex - breathing becomes rapid, shallow, and erratic in a pattern that research has documented objectively using cardiopulmonary exercise testing in ME/CFS patients.[40] A 2025 Frontiers in Medicine study found that 42% of ME/CFS patients met criteria for dysfunctional breathing and 32% showed objective hyperventilation during exercise, compared to 16% and 4% respectively in sedentary controls.[40] At its most severe during a crash, the breathing pattern can feel indistinguishable from a panic attack - except there is no psychological trigger. It is the autonomic nervous system losing control of respiratory regulation as systemic failure cascades.
- Autonomic anxiety: A sense of dread, unease, or anxiety that has no psychological cause - this is the sympathetic nervous system misfiring, flooding the body with stress signals as autonomic regulation fails.
- Digestive shutdown: Nausea, digestive upset, complete loss of appetite. The gut is ANS-controlled; when the ANS fails, digestion fails with it.
Active crash phase (hours 12 to days or weeks):
- Unrestorable exhaustion: Profound fatigue that does not respond to rest. Lying down brings some relief from symptoms that worsen upright, but does not restore energy the way sleep normally would in a healthy person. After 12 hours horizontal, the patient wakes just as depleted as when they lay down - or more depleted, as if the effort of existing consumed what little remained.
- All sensory inputs feel amplified and painful: normal household sounds feel like assault, normal light feels blinding
- Cognitive function may be severely impaired - unable to read, follow conversation, remember words, or process information
- Pain throughout body: muscle aches, joint pain, headache (often pressure or burning in quality), sore throat, swollen lymph nodes
- Sleep disturbance paradoxically worsens - exhausted but unable to achieve restorative sleep
- Temperature dysregulation: feeling simultaneously too hot and too cold, sweating inappropriately
- May be completely bedbound - unable to sit upright, walk to bathroom unaided, or speak without significant effort
- A profound and specific sense of being "poisoned" that patients describe as qualitatively different from any other illness
Recovery phase (days to weeks after crash):
- Symptoms gradually recede - not linearly; there are "false dawns" where improvement reverses
- May not return to pre-crash baseline - repeated crashes can permanently lower functional capacity
- Increased vulnerability to further crashes during recovery: the threshold is lower than usual
- Cognitive recovery often lags behind physical recovery by days
This is what caregivers, family members, and others witness during and after a crash. The gap between what the patient feels and what is visible is enormous - understanding this gap is essential.
- May look normal or "just tired" - the patient often does not look ill in the way an observer expects. There may be no fever, no visible injury, no dramatic presentation. This is the core of invisible illness.
- Withdrawal and unresponsiveness - the patient may stop responding to texts, calls, or questions. This is not rudeness or depression - it is cognitive and energy preservation. Responding uses energy they do not have.
- Cannot be in the same room - during severe crashes, even a caregiver's presence, voice, or movement can worsen symptoms. The patient may ask to be completely alone or in total silence and darkness. This is not rejection.
- Extreme pallor or a grey appearance - reduced blood flow and autonomic dysregulation can visibly affect skin tone during crashes
- Sweating despite not being warm - autonomic dysregulation causes inappropriate diaphoresis (sweating)
- Inability to complete sentences or communicate - the patient may be unable to tell you what they need; they may speak very slowly, lose words mid-sentence, or not be able to respond at all
- Cannot eat or drink without help - in severe crashes, preparing food or drink is impossible; even holding a glass may be difficult
- May be completely bedbound - unable to sit up, go to the bathroom unaided, or leave the room
- Appears "better" during brief windows - brief improvements during a crash do not signal recovery. The patient may have a 30-minute window where they seem functional and then collapse again. Do not interpret windows as evidence that the crash has passed.
- Duration is unpredictable - observers often expect a crash to resolve in hours or a day. Severe crashes can last weeks or months. There is no "appropriate" duration.
The patient is not choosing to be this ill. They are not catastrophizing. The dramatic difference between how they appeared yesterday and how they appear today is real, biological, and beyond their control. The crash will not be shortened by encouragement, positive thinking, or gentle pressure to try to do things. The only thing that shortens a crash is complete removal of all demands - physical, cognitive, sensory, and emotional. Full guide: How to support during a crash →
Crash Severity Levels
Crashes range enormously in severity. Not every PEM episode is a full collapse. Recognizing the spectrum helps patients intervene early before a crash escalates. These describe what is happening during a PEM episode, not baseline function.
Increased fatigue and brain fog for 1-3 days - like functioning through a significant hangover while also having a cold. Can still perform essential activities but at significant cost. Reduced sensory tolerance. Needs extra rest that normal rest does not provide.
Typical duration: 1-3 days with adequate rest.
Must cancel all non-essential activities. Unable to leave home or function at work. Brain fog so severe that reading a paragraph or following a TV show is impossible. Constant flu-like body pain. Sensory overload from anything other than a quiet, dim room.
Typical duration: 3-14 days - weeks of careful management from a single overdone day.
Bedbound. Cannot tolerate visitor presence, any light, or any sound. Cannot prepare food or reach the bathroom unaided. Body pain throughout. Cognitive function nearly absent - cannot hold a conversation or follow a sentence. The body has shut down non-essential functions to preserve whatever energy production remains.
Typical duration: weeks to months.
A single severe crash from which the patient does not fully recover can permanently lower the functional baseline.
Completely dependent on caregivers for all activities. May be unable to speak above a whisper or swallow normally. Tube feeding in extreme cases. The air hunger sensation - constant distressing inability to take a fully satisfying breath - may be continuous. Any stimulation causes worsening.
May represent permanent baseline lowering if these episodes recur.
An estimated 25% of ME/CFS patients reach this severe or very severe level at some point in their illness.
A mild ME/CFS patient can have a severe or very severe crash. These levels describe what is happening during the crash, not the patient's permanent condition. See Baseline Severity Levels for how crashes relate to baseline function.
Pathophysiology
Causes & Biological Mechanisms
ME/CFS is caused by a complex interplay of genetic susceptibility, immune dysregulation, and metabolic dysfunction. For many patients a triggering event can be identified - most commonly an infection. But for a significant number, onset is gradual with no clear trigger at all.
- ME/CFS often begins after an infection (EBV, COVID-19, Lyme, influenza, and others) - but a significant minority of patients have gradual onset with no identifiable trigger. Onset patterns vary enormously: sudden post-viral, gradual over months or years, or following non-infectious events.
- Multiple biological mechanisms are documented: mitochondrial dysfunction, GPCR autoantibodies, neuroinflammation, autonomic failure, gut dysbiosis.
- Gradual onset without a clear trigger is common and valid. Approximately 10-20% of patients report a slow decline over months or years with no identifiable infection or event. This does not make the illness less real or severe - it reflects the diversity of ME/CFS onset pathways.
- The WASF3 protein discovery (2023) provides a molecular explanation for exercise intolerance.
- Genetic susceptibility exists (DecodeME, 2025) but genes alone do not cause ME/CFS - an environmental trigger is required.
- ME/CFS is NOT caused by deconditioning, psychological factors, or "being out of shape."
Triggering Events
Viral Infections
Epstein-Barr virus (EBV/mononucleosis) is the most well-documented trigger. A landmark prospective cohort study (Hickie et al., BMJ 2006) found that approximately 12% of people who had acute EBV, Ross River virus, or Coxiella (Q fever) infection developed ME/CFS-like illness at six months.[34] Other documented triggers include enteroviruses, SARS-CoV-2, HHV-6, CMV, Parvovirus B19, and other acute infections. Up to 72% of ME/CFS cases follow an acute infection of some kind.[6]
Bacterial & Parasitic Infections
Borrelia burgdorferi (Lyme disease), Coxiella burnetii (Q fever), and Giardia have been documented as post-infectious ME/CFS triggers in prospective studies.[34,35] Post-Treatment Lyme Disease Syndrome (PTLDS) overlaps significantly with ME/CFS in symptoms and management, though it requires documented prior Lyme infection by standard criteria.
Non-infectious Triggers
Physical trauma, surgery, and extreme physiological stress have been reported as triggers in a subset of patients, though these are less well-documented than infectious triggers. The 2024 NINDS ME/CFS Research Roadmap notes that "psychological factors, traumatic events, and physical trauma may also be associated with onset of ME/CFS" in some cases, but emphasizes that triggers do not determine the illness's biological nature.[9]
Core Biological Mechanisms (2024-2026 Evidence)
Mitochondrial Dysfunction & Energy Failure
A 2023 study by Wang, Hwang et al. published in PNAS identified WASF3 - a protein that disrupts mitochondrial electron transport chain Complex I - as elevated in ME/CFS muscle tissue.[10] When WASF3 increases under cellular stress, it suppresses mitochondrial respiration, leading to chronic ATP deficiency. This provides a molecular mechanism for exercise intolerance.
Critically, research suggests ME/CFS cells cannot efficiently produce energy even when oxygen is present - a defect at the level of energy extraction rather than oxygen delivery. This helps explain why exertion causes harm rather than adaptation, as seen in healthy people.
Immune Dysregulation & Autoimmunity
The DecodeME genome-wide association study (2024) - the largest ME/CFS genetic study ever conducted, with 15,579 patients and 259,909 controls - identified 29 gene variants associated with ME/CFS. These relate to immune dysregulation, autoimmunity, impaired antiviral immunity, nervous system dysfunction, and mitochondrial function, confirming a genetic and biological basis.[11]
Professor Carmen Scheibenbogen's research group at Charité has documented that a subset of patients have elevated autoantibodies against G-protein coupled receptors (GPCRs) - particularly beta-2 adrenergic receptors and muscarinic acetylcholine receptors - and that these correlate with fatigue severity and cognitive impairment.[12] These receptors regulate blood vessel tone, heart rate, and smooth muscle function, providing a plausible mechanism for autonomic symptoms. A 2024 systematic review found autoimmune mechanisms linked to ME/CFS in at least a subset of patients, with autoantibodies targeting neurotransmitter receptors.[12]
Natural Killer (NK) cell cytotoxic function (not cell count) is reduced in ME/CFS and has been shown to correlate with illness severity - potentially allowing reactivation of latent herpesviruses such as EBV and HHV-6.[13]
Neuroinflammation & Brain Abnormalities
A 2014 PET imaging study by Nakatomi et al. found significant neuroinflammation in ME/CFS brains, particularly in the thalamus, midbrain, and cingulate cortex, correlating with fatigue and cognitive symptom severity.[14] These findings have been supported by subsequent neuroimaging research. The NIH Intramural Study on ME/CFS (Nath, Walitt et al., 2024, Nature Communications) deeply phenotyped post-infectious ME/CFS participants and documented multiple biological abnormalities across immune, neurological, and autonomic systems warranting further investigation in larger cohorts.[15]
Reduced cerebral blood flow is a consistent finding in ME/CFS, worsening upon standing. In the largest controlled study, extracranial Doppler measurements during head-up tilt found a mean 26% reduction in cerebral blood flow across 429 ME/CFS patients, compared with 7% in 44 healthy controls. Ninety per cent of patients fell below the normal range, including 82% of those whose heart rate and blood pressure responses were entirely normal, meaning the abnormality is missed by standard tilt-table criteria alone.[112] Some patients show white matter abnormalities on MRI, but these are not yet validated as diagnostic biomarkers.
Autonomic Nervous System Dysfunction
Autonomic dysfunction is highly prevalent in ME/CFS. Studies have documented sympathetic overactivation, reduced parasympathetic tone (low heart rate variability), and orthostatic cardiovascular abnormalities including POTS and neurally mediated hypotension. A 2022 study in Journal of Translational Medicine found physiological evidence of orthostatic intolerance in a significant majority of CFS patients tested.[16]
Small fiber neuropathy (SFN) - damage to small unmyelinated C-fibers and thinly myelinated A-delta fibers serving autonomic and sensory functions - has been documented via intraepidermal nerve fiber density measurement on skin punch biopsy, potentially explaining both autonomic dysfunction and neuropathic pain. An important caveat: the skin biopsy studies establishing this were conducted in fibromyalgia cohorts rather than ME/CFS cohorts. Because 35-70% of ME/CFS patients also meet fibromyalgia criteria, these findings are widely considered relevant here, but small fibre neuropathy has not yet been directly established in a dedicated ME/CFS population. Research in ME/CFS-specific cohorts is needed.[17]
Microcirculatory & Blood Flow Abnormalities
Studies have documented reduced red blood cell deformability in ME/CFS - stiff cells that cannot efficiently navigate small capillaries, impairing tissue oxygenation.[18] Fibrin amyloid microclots - similar to those extensively documented in long COVID - have also been identified in at least some ME/CFS patients, though this research is still developing.[19]
Gut Microbiome Dysbiosis
Multiple studies have documented altered gut microbiome composition in ME/CFS compared to healthy controls, including reduced populations of beneficial species such as Faecalibacterium prausnitzii and Bifidobacterium, and higher levels of potentially pro-inflammatory species. A 2021 study found a distinct microbiome signature in ME/CFS patients that correlated with symptom severity.[20]
Increased intestinal permeability ("leaky gut") has been documented in ME/CFS, potentially allowing bacterial products such as lipopolysaccharides (LPS) to enter the circulation and drive systemic immune activation. Altered metabolite profiles in stool and blood, consistent with gut-immune-brain axis dysfunction, have been reported in multiple metabolomics studies.[21]
Metabolic Dysfunction & Metabolomics
Naviaux et al. (2016, PNAS) reported a hypometabolic signature in ME/CFS using untargeted metabolomics, with abnormalities across multiple pathways including sphingolipid metabolism and purine metabolism - a pattern resembling a cell-danger response.[22] While this was a small study requiring replication, the metabolomics approach has been supported by subsequent work.
Impaired aerobic energy production, with patients over-relying on anaerobic glycolysis, has been objectified using the two-day cardiopulmonary exercise test (2-day CPET). ME/CFS patients consistently show a significant decline in peak oxygen consumption (VO2 peak) and anaerobic threshold on the second day of testing - a pattern not seen in healthy controls or most other chronic diseases - providing objective evidence of PEM.[23]
"We understand the pathophysiology of ME much better than we used to, including the central role of neuroinflammation and the interaction of abnormalities in various systems such as the autonomic nervous system, circulatory, immune system, endocrine, and energy metabolism." - Dr. Luis Nacul, IACFS/ME Board Member, IACFS/ME 2025 Conference